Top 10 ADHD News and Research Headlines of 2025
An editorial round-up of the scientific studies and findings most likely to impact our readers’ lives and health.
December 5, 2025
This year, we confirmed that ADHD prevalence rates remain stable and new diagnoses do not indicate an “epidemic,” but they do suggest improved research and diagnostic tools. We learned how ADHD reduces life expectancy by up to 9 years — and how ADHD medication can protect against adverse outcomes. We also saw the discovery of two new genetic profiles of autism that dispel the idea that it is a single condition with a single cause. Here, read all the top news and research headlines of 2025, according to ADDitude editors.
1. MAHA Commission Draws Swift Criticism, Condemnation
The Make America Healthy Again Commission, chaired by Health and Human Services Director Robert F. Kennedy, Jr., drew rebukes from medical and advocacy groups as well as ADDitude community members for singling out autism spectrum disorder and ADHD, claiming without proof that the “over-utilization of medication” for those and other conditions “pose a dire threat to the American people and our way of life.”
The commission, established by executive order, aims to combat ADHD, autism, and other chronic health conditions with “fresh thinking on nutrition, physical activity, healthy lifestyles, over-reliance on medication and treatments, the effects of new technological habits, environmental impacts, and food and drug quality and safety,” Kennedy said in February.
Continue reading “MAHA Commission Draws Swift Criticism, Condemnation” to learn more.
2. ADHD Reduces Life Expectancy by 7 to 9 Years
Life expectancy for people with ADHD is 7.5 years shorter than it is for those without the condition, revealed ground-breaking research published in The British Journal of Psychiatry.1 What’s more, the life expectancy for a woman with ADHD is 8.6 years shorter compared to her neurotypical peers, a slightly larger gap than the 6.8-year difference for men.
“Adults with diagnosed ADHD are living shorter lives than they should,” the researchers wrote. “We believe that is likely caused by modifiable risk factors and unmet support and treatment needs in terms of both ADHD and co-occurring mental and physical health conditions.”
The January study was the first of its kind to examine the life expectancy of adults with ADHD using mortality data from the health records of more than 9.5 million people with and without ADHD.
Continue reading “ADHD Reduces Life Expectancy by 7 to 9 Years” to learn more.
3. Sex Hormones in Women Impact ADHD Symptoms, Medication Efficacy
Fluctuating estrogen and progesterone levels in females across the lifespan influence inattention, impulsivity, and emotional dysregulation as well as the efficacy of ADHD medication, according to a systematic review published in May in the Journal of Attention Disorders.2
“There is an ADHD experience that is unique to females,” the study’s authors wrote. “Recognizing potential influences of sex hormones on ADHD symptoms in females may have key implications for clinical management and treatment of ADHD.”
The review included 11 studies that investigated puberty, pregnancy, postpartum, and the menstrual cycle and tracked changes in symptomology and in the efficacy of ADHD medication during these times.
Continue reading “Sex Hormones in Women Impact ADHD Symptoms, Medication Efficacy” to learn more.
4. ADHD Medication Use Lowers the Risk of Suicidality, Criminality, Drug Misuse, Car Accidents
Untreated ADHD can lead to serious consequences. However, ADHD medication significantly reduces the rates of first-time and recurrent suicidality, criminal behaviors, vehicular accidents, and substance misuse, found a study of nearly 150,000 people with ADHD published in the BMJ.3 In addition, ADHD medication use substantially decreases the risk of lethal events when it begins within three months of a diagnosis.
“Public discourse, media coverage, and interactions with individuals affected by ADHD show that many patients and caregivers lack awareness of the risks and benefits of ADHD drug treatment, leading to uncertainty in treatment decisions,” the study’s authors wrote. “This knowledge gap served as a key motivation for our research.”
Continue reading “ADHD Medication Use Lowers the Risk of Suicidality, Criminality, Drug Misuse, Car Accidents” to learn more.
5. A New, Bifurcated View of Autism Emerges in Genetic Research
Autism diagnosed in early childhood is genetically distinct from autism diagnosed after age 10, according to an October study that identified two unique genetic profiles in early- and later-diagnosed autistic individuals.4 The study, published in Nature, determined that later-diagnosed autism had a more significant genetic correlation to ADHD, as well as mental health conditions including depression and post-traumatic stress disorder (PTSD).
The results of the study challenge the assumption that autism is one single condition and highlight the heterogeneity of its causes, comorbidities, and manifestations.
Continue reading “A New, Bifurcated View of Autism Emerges in Genetic Research” to learn more.
6. Background Music, Amplitude Modulation Improves Focus for ADHD Brains
Stimulating music, and specifically songs with strong, targeted amplitude modulations, may increase attention and improve cognition in adults with ADHD symptoms.
A peer-reviewed study published in the journal Communications Biology found that listening to heavily modulated music — rhythmic pulses not typically found in music — sustains attention in people with ADHD symptoms by engaging the brain regions responsible for cognitive control.5
Another related study published in Frontiers in Psychology reported that young adults with ADHD symptoms prefer listening to stimulating music and background music while studying and engaging in sports and other less cognitively demanding activities significantly more than their neurotypical peers do.6 Both studies underscore the positive effects of music on ADHD brains.
Continue reading “Background Music, Amplitude Modulation Improves Focus for ADHD Brains” to learn more.
7. Hypermobility Often Misdiagnosed as Mental Illness
Almost 94.4% of hypermobile Ehler-Danlos Syndrome (hEDS) patients were incorrectly diagnosed with a mental illness by a non-psychiatrist before receiving their hEDS diagnosis, and 88% reported being told by providers that they were “making up” their symptoms, according to research published in the journal Children.7
Findings from another, related study published in Brain, Behavior, & Immunity – Health revealed that patients with MCAS are at higher risk for 18 neuropsychiatric disorders, including ADHD; female mast cell activation syndrome (MCAS) patients are three times more likely to have ADHD than are controls. Rates of OCD, bipolar disorder, suicidality, and anxiety were also significantly higher in patients with MCAS, who reported improvement of symptoms after MCAS treatment, including with antihistamines.8
Together, these new studies help elucidate the interplay between neuropsychiatric (and pseudo-neuropsychiatric) symptoms and the multi-system disorders hEDS and MCAS, which are highly prevalent among people with ADHD.
Continue reading “Hypermobility Often Misdiagnosed as Mental Illness” to learn more.
8. Rise in ADHD Diagnoses Reflects Greater Education, Not Prevalence
ADHD prevalence in adults and children remains stable, suggesting that the steady increase in new ADHD diagnoses does not indicate an “epidemic,” but it suggests improved research and diagnostic tools, according to a systematic review published in the Journal of Attention Disorders.9
The study found no significant increase in ADHD prevalence rates among children and adults from 2020 to 2024 compared to earlier time periods. ADHD evaluations did increase during and following the COVID-19 pandemic; however, resulting diagnoses did not change the overall prevalence of ADHD in the population, the study found.
The findings challenge assumptions made in the media and by some U.S. government agencies about a ‘surge’ in ADHD diagnoses following the COVID-19 pandemic.
“Prevalence refers to the overall occurrence of ADHD in the population at a particular point in time,” Russell Barkley, Ph.D., a leading authority on ADHD, explained on his YouTube channel. “Incidence refers to the occurrences of newly identified ADHD cases within a specific period. There can be a dramatic difference between prevalence and incidence, where there is no change in prevalence but a rise in incidence because new cases of ADHD are already present. They just weren’t identified.”
Continue reading “Rise in ADHD Diagnoses Reflects Greater Education, Not Prevalence” to learn more
9. Stimulants Reduce Narcissistic Personality Traits, Increase Empathy in ADHD Adults
Narcissistic personality traits are curbed, and empathy improved, by the use of stimulant medication in adults who have ADHD, according to a small study published in Alpha Psychiatry.10 The study was the first to explore the impact of ADHD medication on narcissistic personality traits and empathy in adult patients with ADHD, building on past research that established a high prevalence of narcissistic personality disorder (NPD) in this population.
This research comes just months after another study, published in the Journal of Psychiatric Research, explored the link between pathological narcissism and ADHD.11 The Journal of Psychiatric Research study offered further insight into the link between ADHD and narcissism, revealing that narcissistic traits tied to both grandiose and vulnerable subtypes were associated with symptoms of hyperactivity and impulsivity, but not with inattention.
Continue reading “Stimulants Reduce Narcissistic Personality Traits, Increase Empathy In ADHD Adults” to learn more.
10. Benefits of Vitamin D for ADHD Include Improved Hyperactivity, Attention
Vitamin D supplementation is associated with decreased ADHD symptoms, including lower levels of hyperactivity and inattention in children, finds a meta-analysis published in The PCMC Journal, which reviewed six studies of children with ADHD who received vitamin D supplements or placebos.12
The children treated with vitamin D exhibited decreased ADHD symptoms, including lower scores of hyperactivity and inattention, with no significant side effects. The researchers concluded that vitamin D should be pursued as an adjuvant to methylphenidate for children with ADHD.
“Given the robust evidence and well-structured, randomized controlled trials, we strongly advocate for the integration of vitamin D supplementation with ADHD treatment,” they wrote.
Findings from the study build on previous research that found relatively lower levels of vitamin D in children with ADHD compared to their neurotypical peers.13
Continue reading “ Benefits of Vitamin D for ADHD Include Improved Hyperactivity, Attention: Meta-Analysis” to learn more.
Top ADHD News & Research of 2025: Honorable Mentions
- Methylphenidate, Atomoxetine Safe to Use in Pregnancy
- CDC to Study Vaccines and Autism Despite Extensive Evidence Showing No Link
- Serotonin Dysregulation Is the Common Denominator in Most ADHD Comorbidities
View Article Sources
1O’Nions, E., El Baou, C., John, A., Lewer, D., Mandy, W., McKechnie, D. G. J., et al. (2025). Life expectancy and years of life lost for adults with diagnosed ADHD in the UK: matched cohort study. The British Journal of Psychiatry, 1–8. https://doi.org/10.1192/bjp.2024.199
2Osianlis, E., Thomas, E. H. X., Jenkins, L. M., & Gurvich, C. (2025). ADHD and sex hormones in females: A systematic review. Journal of Attention Disorders. https://doi.org/10.1177/10870547251332319
3Zhang. L., Zhu, N., Sjölander, A., Nourredine, M., Li, L., Garcia-Argibay, M. et al. (2025). ADHD drug treatment and risk of suicidal behaviours, substance misuse, accidental injuries, transport accidents, and criminality: emulation of target trials. BMJ. https://doi.org/10.1136/bmj-2024-083658
4Zhang, X., Grove, J., Gu, Y., Buus, C.K., Nielsen, L.K., Neufeld, S.A., Koko, M., Malawsky, D.S., Wade, E.M., Verhoef, E., Gui, A., Hegemann, L., Geschwind, D.H., Wray, N.R., Havdahl, A., Ronald, A., St Pourcain, B., Robinson, E.B., Bourgeron, T., Warrier, V. (2025). Polygenic and developmental profiles of autism differ by age at diagnosis. Nature.https://doi.org/10.1038/s41586-025-09542-6
5Woods, K.J.P., Sampaio, G., James, T. et al. (2024). Rapid modulation in music supports attention in listeners with attentional difficulties. Commun Biol. 7, 1376.https://doi.org/10.1038/s42003-024-07026-3
6Lachance, K., & Gosselin, N. (2025). Listening habits and subjective effects of background music in young adults with and without ADHD. Frontiers in Psychology. 15, 1508181. https://doi.org/10.3389/fpsyg.2024.1508181
7Lee, C.; Chopra, P. (2025). The incidence of misdiagnosis in patients with Ehlers–Danlos Syndrome. Children. 12, 698.https://doi.org/10.3390/children12060698
8Weinstock, L.B., Afrin, L.B., Reiersen, A.M., Brook, J., Blitshteyn, S., Ehrlich, G., Schofield, J.R., Kinsella, L., Kaufman, D., Dempsey, T., & Molderings, G.J. (2025). Prevalence and treatment response of neuropsychiatric disorders in mast cell activation syndrome. Brain, Behavior, & Immunity – Health. 48, 101048.https://doi.org/10.1016/j.bbih.2025.101048
9Martin, A.F., Rubin, G.J., Rogers, M.B., Wessely, S., Greenberg, N., Hall, C.E., Pitt, A., Logan, P.E., Lucas, R., & Brooks, S.K. (2025). The changing prevalence of ADHD? A systematic review. Journal of Affective Disorders.https://doi.org/10.1016/j.jad.2025.119427
10Takim, U., Belli, H., Gökçay, H., Köse, H., Arslan Akgül, H., Çakir, A. (2024). Examination of changes in levels of empathy and narcissistic pathology after treatment of adult with attention-deficit/hyperactivity disorder. Alpha Psychiatry. https://doi.org/10.5152/alphapsychiatry.2024.241630
11Duarte, M., Blay, M., Hasler, R., Pham, E., Nicastro, R., Jan, M., Debbané, M., Perroud, N. (2024) Adult ADHD and pathological narcissism: A retrospective-analysis. J Psychiatr Res.https://doi.org./10.1016/j.jpsychires.2024.04.032
12Latorre, C.G. & Mañalac, A.S. (2025). Effects of Vitamin D supplementation on pediatric attention deficit hyperactivity disorder: a meta-analysis and systematic review. The PCMC Journal. https://www.ejournals.ph/article.php?id=26969
13Kotsi, E., Kotsi, E., Perrea, D.N. (2019). Vitamin D levels in children and adolescents with attention-deficit hyperactivity disorder (ADHD): a meta-analysis. Attention deficit hyperactivity disord. https://doi.org/10.1007/s12402-018-0276-7
